Cellular mechanisms of insulin resistance in polycystic ovarian syndrome

Cited by (336)

Items 101–200 of 336

1. Evidence for the Presence of Glucose Transporter 4 in the Endometrium and Its Regulation in Polycystic Ovary Syndrome Patients
   Roberto Mioni, Silvia M. Chiarelli, N. Xamin, L. Zuliani, Marnie Granzotto, Bruno Mozzanega, Pietro Maffei, Chiara Martini, Stella Blandamura, Nicola Sicolo et al. · 2004 · The Journal of Clinical Endocrinology & Metabolism
2. The Effect of Nutrient Supplementation in Management of Polycystic Ovary Syndrome Associated Metabolic Dysfunctions: A Critical Review
   Günalan, Elif, Yaba, Aylin, Yılmaz, Bayram · 2018 · Journal of the Turkish-German Gynecological Association
3. Anthropometric, clinical, and metabolic comparisons of the four Rotterdam PCOS phenotypes: A prospective study of PCOS women
   Sujata Kar · 2013 · Journal of Human Reproductive Sciences
4. Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS
   Emma J Houston, Nicole M. Templeman · 2025 · Journal of Endocrinology
5. Glucose Metabolism and Insulin Resistance in Women with Polycystic Ovary Syndrome during Therapy with Oral Contraceptives Containing Cyproterone Acetate or Desogestrel
   Angelo Cagnacci, Anna Maria Paoletti, A. Renzi, Martino Orrù, Monica Pilloni, Gian Benedetto Melis, Annibale Volpe · 2003 · The Journal of Clinical Endocrinology & Metabolism
6. Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
   Torchen, Laura C. · 2017 · Current Diabetes Reports
7. Zinc and Homocysteine Levels in Polycystic Ovarian Syndrome Patients with Insulin Resistance
   İsmail Güler, Özdemir Himmetoğlu, Ahmet Berkız Turp, Ahmet Erdem, Mehmet Erdem, Mehmet Anıl Onan, Çağatay Taşkıran, Mine Yavuz Taşlıpınar, Haldun Güner · 2014 · Biological Trace Element Research
8. Prevention of diabetes and cardiovascular disease in women with PCOS: Treatment with insulin sensitizers
   Susmeeta T. Sharma, John E. Nestler · 2006 · Best Practice & Research Clinical Endocrinology & Metabolism
9. Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery
   Kok‐Min Seow, Chi‐Chang Juan, Yung-Pei Hsu, Jiann‐Loung Hwang, Lee‐Wen Huang, Low‐Tone Ho · 2007 · Human Reproduction
10. Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome
    Lynn R. Sorbara, Zhichun Tang, Alessandro Cama, Jinru Xia, Esther Schenker, Ronald A. Kohanski, Leonid Poretsky, Elizabeth A. Koller, Simeon I. Taylor, Andrea Elizabeth Dunaif · 1994 · Metabolism
11. Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial
    Angelo Cagnacci, Serena Ferrari, Alessandra Tirelli, Renata Zanin, Annibale Volpe · 2008 · Contraception
12. New perspectives in polycystic ovary syndrome
    Evanthia Diamanti‐Kandarakis, Andrea Elizabeth Dunaif · 1996 · Trends in Endocrinology and Metabolism
13. Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome
    Osman Yüksel, Hatice Sebila Dökmetaş, Saniye Topçu, Taner Erselcan, Mehmet Şencan · 2001 · Journal of Bone and Mineral Metabolism
14. Insulin resistance improves in hyperandrogenic women treated with Lupron
    Karen E Elkind-Hirsch, Cecilia T. Valdés, L. Russell Malinak · 1993 · Fertility and Sterility
15. The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females.
    Ferdous Mehrabian, Behnaz Khani, Roya Kelishadi, Narges Kermani · 2011 · Europe PMC (PubMed Central)
16. The Hormonal Phenotype of Nonclassic 3β-Hydroxysteroid Dehydrogenase (HSD3B) Deficiency in Hyperandrogenic Females Is Associated with Insulin-Resistant Polycystic Ovary Syndrome and Is Not a Variant of Inherited HSD3B2 Deficiency
    Goldy Carbunaru, Pallavi Prasad, Bert Scoccia, Patrick Shea, Nancy J. Hopwood, Fuad Ziai, Ying Chang, Susan E. Myers, J. Ian Mason, Songya Pang · 2004 · The Journal of Clinical Endocrinology & Metabolism
17. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome
    Miguel Ángel Checa, A. Requena, Cristina Salvador, Rosa Tur, J. Callejo, Juan José Espinós, Francisco Fábregues, Judith Cacho Herrero, (Reproductive Endocrinology Interest Group of the Spanish Society of Fertility) · 2005 · Human Reproduction Update
18. Hyperhomocysteinemia Promotes Insulin Resistance and Adipose Tissue Inflammation in PCOS Mice Through Modulating M2 Macrophage Polarization via Estrogen Suppression
    Xinyu Qi, Bochun Zhang, Yue Zhao, Rong Li, Hsun‐Ming Chang, Yanli Pang, Jie Qiao · 2017 · Endocrinology
19. Physical Growth and Endocrinal Disorders during Pubertal Maturation in Girls with Epilepsy
    Hamed A. El‐Khayat, Fatma Z. Abd El‐Basset, Hoda Yahya Tomoum, Saeid M. Tohamy, Amira A. Zaky, Mervat Sayed Mohamed, Suzan M. Hakky, Nancy Samir Elbarbary, Nermin M. Nassef · 2004 · Epilepsia
20. Polycystic ovarian syndrome (PCOS) and insulin resistance
    K.H Park, J.Y Kim, Chul Woo Ahn, Young Duk Song, Sung-Kil Lim, H.C Lee · 2001 · International Journal of Gynecology & Obstetrics
21. Insulin Resistance in Polycystic Ovarian Syndromea
    Andrea Elizabeth Dunaif · 1993 · Annals of the New York Academy of Sciences
22. Polycystic Ovary Syndrome in Adolescents
    Carla Pelusi, Renato Pasquali · 2003 · Treatments in Endocrinology
23. DECREASES IN OVARIAN CYTOCHROME P450c17 a ACTIVITY AND SERUM FREE TESTOSTERONE AFTER REDUCTION OF INSULIN SECRETION IN POLYCYSTIC OVARY SYNDROME
    J Ohn E. N Estler, Aniela J. J Akubowicz · 2011
24. Body Composition and Regional Fat Distribution in Polycystic Ovarian Syndrome Relationship to Hormonal and Metabolic Profiles
    J. Bringer, Patrick Lefebvre, F. Boulet, Florin Grigorescu, Éric Renard, Bernard Hedon, Andrea Orsetti, Claude Jaffiol · 1993 · Annals of the New York Academy of Sciences
25. Insulin-like growth factor-I increases expression of the porcine P-450 cholesterol side chain cleavage gene through a GC-rich domain.
    Randall J. Urban, Margaret A. Shupnik, Yvonne H. Bodenburg · 1994 · Journal of Biological Chemistry
26. Obesity Reduces the Expression of GLUT4 in the Endometrium of Normoinsulinemic Women Affected by the Polycystic Ovary Syndrome
    Bruno Mozzanega, Roberto Mioni, Marnie Granzotto, Silvia M. Chiarelli, N. Xamin, L. Zuliani, Nicola Sicolo, D. Marchesoni, Roberto Vettor · 2004 · Annals of the New York Academy of Sciences
27. Elevated Chemerin Induces Insulin Resistance in Human Granulosa-Lutein Cells from Polycystic Ovary Syndrome Patients
    Xiaoxue Li, Qinling Zhu, Wangsheng Wang, Jia Qi, Yaqiong He, Yuan Wang, Yao Lu, Hasiximuke Wu, Ying Ding, Yun Wei Sun · 2018 · The FASEB Journal
28. Clinical, endocrine and metabolic effects of acarbose, an α-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance
    Lilliana Ciotta, Aldo Eugenio Calogero, Marco Farina, Vincenzo De Leo, Antonio La Marca, Antonio Cianci · 2001 · Human Reproduction
29. Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo
    Madhurima Rajkhowa, Sandra Brett, Daniel James Cuthbertson, Christopher Lipina, Antonio J. Ruiz‐Alcaraz, G. E. Thomas, Lisa Logie, John R. Petrie, Calum D. Sutherland · 2008 · Biochemical Journal
30. Disorders of Androgen Synthesis – from Cholesterol to Dehydroepiandrosterone
    Walter L. Miller · 2005 · Medical Principles and Practice
31. Polycystic Ovary Syndrome And Hyperprolactinemia
    Nabal Jose Bracero, Howard A. Zacur · 2001 · Obstetrics and Gynecology Clinics of North America
32. Hyperinsulinism and Its Interaction With Hyperandrogenism in Polycystic Ovary Syndrome
    Ibrahim Sozen, Aydin M. Arici · 2000 · Obstetrical & Gynecological Survey
33. The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome
    Anne M. Corbould, Andrea Elizabeth Dunaif · 2007 · Metabolism
34. Selective alterations in insulin receptor substrates-1, -2 and -4 in theca but not granulosa cells from polycystic ovaries
    H-W. Yen · 2004 · Molecular Human Reproduction
35. Use of metformin in the treatment of polycystic ovary syndrome
    Genazzani, Alessandro D, Ricchieri, Federica, Lanzoni, Chiara · 2010 · Women's Health
36. Polycystic Ovary Syndrome, Insulin Resistance, and Molecular Defects of Insulin Signaling
    Ricardo Azziz · 2002 · The Journal of Clinical Endocrinology & Metabolism
37. Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: A retrospective analysis
    Sharma, Susmeeta T., Wickham, Edmond P., Nestler, John E. · 2007 · Endocrine Practice
38. Long non-coding RNA lnc-CCNL1-3:1 promotes granulosa cell apoptosis and suppresses glucose uptake in women with polycystic ovary syndrome
    Jiayu Huang, Jun Zhao, Xueying Geng, Weiwei Chu, Shang Li, Zi‐Jiang Chen, Yanzhi Du · 2020 · Molecular Therapy — Nucleic Acids
39. Polycystic ovary syndrome: Current and future treatment paradigms
    Richard S. Legro · 1998 · American Journal of Obstetrics and Gynecology
40. Metformin alters insulin signaling and viability of human granulosa cells
    Barbara Sonntag, Martin Götte, Pia Wülfing, Andreas N. Schüring, Ludwig Kiesel, Robert R. Greb · 2005 · Fertility and Sterility
41. Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
    Jensterle, Mojca, Janez, Andrej, Mlinar, Barbara, Marc, Janja, Prezelj, Janez, Pfeifer, Marija · 2008 · European Journal of Endocrinology
42. Obese and non-obese polycystic ovarian syndrome: Comparison of clinical, metabolic, hormonal parameters, and their differential response to clomiphene
    Shalini Gainder, Garima Sachdeva, Vanita Suri, Naresh Kumar Sachdeva, Seema Chopra · 2019 · Indian Journal of Endocrinology and Metabolism
43. Polycystic ovary syndrome: an endocrine and metabolic disease
    Antonietta Maria Scarpitta, Domenico Sinagra · 2000 · Gynecological Endocrinology
44. Insulin resistance and metformin in polycystic ovary syndrome
    Avi Ben‐Haroush, Yariv Yogev, Benjamin Fisch · 2004 · European Journal of Obstetrics & Gynecology and Reproductive Biology
45. Polycystic Ovarian Syndrome in Women with Epilepsy: A Review
    Susan Duncan · 2001 · Epilepsia
46. Tissue insulin sensitivity and body weight in polycystic ovary syndrome
    Philippa J. Marsden, Alison P. Murdoch, Roy Taylor · 2001 · Clinical Endocrinology
47. Ovarian cycle-specific regulation of adipose tissue lipid storage by testosterone in female nonhuman primates.
    O. Varlamov, Michael P Chu, W. McGee, J. Cameron, R. O'Rourke, Kevin A. Meyer, C. Bishop, R. Stouffer, C. Roberts · 2013 · Endocrinology
48. Evaluation of TNF-α and IL-6 mRNAs expressions in visceral and subcutaneous adipose tissues of polycystic ovarian rats and effects of resveratrol.
    Mahnaz Ghowsi, Homayoun Khazali, Sajjad Sisakhtnezhad · 2018 · Europe PMC (PubMed Central)
49. The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis
    Eliran Mor, Arus Zograbyan, Peyman Saadat, Aykut Bayrak, David E Tourgeman, Chunying Zhang, Frank Z. Stanczyk, Richard J. Paulson · 2004 · American Journal of Obstetrics and Gynecology
50. The Expression of the miR-25/93/106b Family of Micro-RNAs in the Adipose Tissue of Women With Polycystic Ovary Syndrome
    Hsiao-Li Wu, Saleh G. Heneidi, Tung-Yueh Chuang, Michael P. Diamond, Lawrence Clarke Layman, Ricardo Azziz, Yen-Hao Chen · 2014 · The Journal of Clinical Endocrinology & Metabolism
51. Polycystic Ovary Syndrome and Hyperandrogenic States
    R. Jeffrey Chang, Daniel Anthony Dumesic · 2019 · Elsevier eBooks
52. Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome
    A.Süha Sönmez, Levent Yaşar, Kadir Savan, S. Koç, John Ozcan, Asiye Toklar, Fehmi Yazıcıoğlu, A. Akgün, Necdet Süt · 2004 · Human Reproduction
53. Impaired insulin action on granulosa-lutein cells in women with polycystic ovary syndrome and insulin resistance
    Péter Fedorcsák, Ritsa Storeng, Per Olav Dale, Tom Gunnar Tanbo, Thomas Åbyholm · 2000 · Gynecological Endocrinology
54. A landscape analysis of the potential role of polyphenols for the treatment of Polycystic Ovarian Syndrome (PCOS)
    Raksha Rani, Younis Ahmad Hajam, Rajesh Kumar, Rouf Ahmad Bhat, Seema Rai, Manzoor Ahmad Rather · 2021 · Phytomedicine Plus
55. Polycystic ovary syndrome is associated with genetic polymorphism in the insulin signaling gene IRS-1 but not ENPP1 in a Japanese population
    Tsuyoshi Baba, Toshiaki Endo, Fumihiro Sata, Hiroyuki Honnma, Yoshimitsu Kitajima, Takuhiro Hayashi, Kengo Manase, Mika Kanaya, Hideto Yamada, Hisanori Minakami et al. · 2007 · Life Sciences
56. Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome
    Preeti Dabadghao, Bronwen J Roberts, Jim Jian Wang, Michael J. Davies, Robert John Norman · 2007 · The Medical Journal of Australia
57. Electrical vs Manual Acupuncture Stimulation in a Rat Model of Polycystic Ovary Syndrome: Different Effects on Muscle and Fat Tissue Insulin Signaling
    Julia Johansson, Louise Mannerås-Holm, Ruijin Shao, AnneLiese Olsson, Malin Lönn, Håkan Billig, Elisabet Stener‐Victorin · 2013 · PLoS ONE
58. From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management
    Pani, Arianna, Gironi, Ilaria, Di Vieste, Giacoma, Mion, Elena, Bertuzzi, Federico, Pintaudi, Basilio · 2020 · International Journal of Endocrinology
59. Relationship between insulin resistance and gonadotropin dissociation in obese and nonobese women with polycystic ovary syndrome
    Carlos Morán, Edgardo García-Hernández, Edgar Barahona, Sandra González, JOSE A. BERMUDEZ · 2003 · Fertility and Sterility
60. Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implications
    Ann E. Taylor · 1998 · American Journal of Obstetrics and Gynecology
61. Interface between Extra‐ and Intraovarian Factors in Polycystic Ovarian Syndrome
    YEN, S. S. C., LAUGHLIN, G. A., MORALES, A. J. · 1993 · Annals of the New York Academy of Sciences
62. The Role Of The Adrenal Cortex In Polycystic Ovary Syndrome
    Carlos Morán, Ricardo Azziz · 2001 · Obstetrics and Gynecology Clinics of North America
63. Association of IRS-1 and IRS-2 genes polymorphisms with polycystic ovary syndrome: a meta-analysis
    Yuan Ruan, Jianhua Ma, Xiaojing Xie · 2012 · Endocrine Journal
64. Insulin Resistance in the Polycystic Ovary Syndrome
    Andrea Elizabeth Dunaif, C. B. Book · 1997 · Humana Press eBooks
65. Hyperinsulinemia in the polycystic ovary syndrome: a clinical, endocrine and echographic study in 240 patients
    Leopoldo Falsetti, Georgios Eleftheriou · 1996 · Gynecological Endocrinology
66. Combined androgen excess and Western-style diet accelerates adipose tissue dysfunction in young adult, female nonhuman primates
    Varlamov, Oleg, Bishop, Cecily V., Handu, Mithila, Takahashi, Diana, Srinivasan, Sathya, White, Ashley, Roberts, Charles T. · 2017 · Human Reproduction
67. Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome
    Alessandra Fusco, Antonio Bianchi, A. Mancini, Domenico Milardi, Antonella Giampietro, V. Cimino, Teresa Porcelli, Daniela Romualdi, Maurizio Guido, Antonio Lanzone et al. · 2007 · Journal of Endocrinological Investigation
68. Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study
    İbrahim Şahin, Rüştü Serter, Feridun Karakurt, Baha T. Demirbas, Cavit Çulha, Çağatay Taşkapan, Feridun Koşar, Yalçın Aral · 2004 · Gynecological Endocrinology
69. Insulin and polycystic ovary syndrome: A new look at an old subject
    Mario Ciampelli, A. Lanzone · 1998 · Gynecological Endocrinology
70. Polycystic ovary syndrome: clinical considerations.
    K Marshall · 2001 · PubMed
71. Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism
    Angelo Cagnacci · 1999 · Human Reproduction
72. Insulin resistance and the polycystic ovary syndrome
    Guiqin Hao · 2005 · Journal of reproductive medicine
73. Association Between Polycystic Ovary Syndrome and Glucose Intolerance During Pregnancy
    Karen B. Lesser, Francisco García · 1997 · The Journal of Maternal-Fetal Medicine
74. No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome
    Daniela Söderlund, Patricia Canto, Sebastián Carranza‐Lira, Juan Pablo Méndez · 2005 · Human Reproduction
75. Clomiphene citrate reduces serum insulin-like growth factor I and increases sex hormone-binding globulin levels in women with polycystic ovary syndrome
    Tarja L. Bützow, L. Michael Kettel, Samuel S.C. Yen · 1995 · Fertility and Sterility
76. Insulin-Mediated Substrate Use in Women With Different Phenotypes of PCOS: the Role of Androgens
    Flavia Tosi, Michela Villani, Matteo Migazzi, Giulia Faccin, Sabrina Garofalo, Tom Fiers, Jean‐Marc Kaufman, Enzo Bonora, Paolo Moghetti · 2021 · The Journal of Clinical Endocrinology & Metabolism
77. Insulin Resistance in PCOS
    Evanthia Diamanti‐Kandarakis, Charikleia D. Christakou · 2009 · Springer eBooks
78. The long term health consequences of polycystic ovary syndrome
    Christopher J. Kelly, John Connell, Iain T. Cameron, Gwyn W. Gould, Helen Lyall · 2000 · BJOG An International Journal of Obstetrics & Gynaecology
79. Targeting adipokines in polycystic ovary syndrome and related metabolic disorders: from experimental insights to clinical studies
    Yidan Xu, Huiqiu Zhu, Weiwei Li, Danxia Chen, Ying Xu, Aimin Xu, Dewei Ye · 2022 · Pharmacology & Therapeutics
80. Adipocyte expression of glucose transporter 1 and 4 in PCOS: Relationship to insulin‐mediated and non–insulin‐mediated whole‐body glucose uptake
    Uche I. Ezeh, Yii‐Der Ida Chen, Yen‐Hao Chen, Ricardo Azziz · 2019 · Clinical Endocrinology
81. Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome
    Theodore P. Ciaraldi, Arlene J. Morales, Matthew G. Hickman, Rosanne Odom-Ford, Samuel S.C. Yen, Jerrold M. Olefsky · 1998 · Metabolism
82. Diabetes detection in women with gestational diabetes and polycystic ovarian syndrome
    Fahmy Hanna, Pensée Wu, Adrian Hugh Heald, Anthony A. Fryer · 2023 · BMJ
83. Effect of Preconception Impaired Glucose Tolerance on Pregnancy Outcomes in Women With Polycystic Ovary Syndrome
    Daimin Wei, Bo Zhang, Yuhua Shi, Lin Zhang, Shigang Zhao, Yanzhi Du, Lizhen Xu, Richard S. Legro, Heping Zhang D, Zi‐Jiang Chen · 2017 · The Journal of Clinical Endocrinology & Metabolism
84. Association of Insulin Resistance with Hyperandrogenia in Women
    MICHEL M. PUGEAT, Pierre‐Henri Ducluzeau, Marika Mallion-Donadieu · 2000 · Hormone Research in Paediatrics
85. Insulin enhances the transcription of luteinizing hormone-β gene
    Christoph Dorn, Jean‐François Mouillet, Xiaomei Yan, Qinglin Ou, Yoel Sadovsky · 2004 · American Journal of Obstetrics and Gynecology
86. Role of insulin in the neuroendocrine control of reproduction
    Maggie C. Evans, Jennifer Wootton Hill, Greg M. Anderson · 2021 · Journal of Neuroendocrinology
87. Polycystic ovary syndrome: a review for primary providers
    Janet M. Buccola, Eileen E. Reynolds · 2003 · Primary Care Clinics in Office Practice
88. Plasma Dehydroepiandrosterone and Risk of Myocardial Infarction in Women
    John H. Page, Jing Ma, Kathryn M. Rexrode, Nader Rifai, JoAnn E. Manson, Susan E. Hankinson · 2008 · Clinical Chemistry
89. Insulin resistance in polycystic ovary syndrome: treating a phenotype without a genotype
    Richard S. Legro · 1998 · Molecular and Cellular Endocrinology
90. Insulin Resistance in Adolescents with Menstrual Irregularities
    Adriana Rodrigues Fernandes, Ana Carolina Japur de Sá Rosa e Silva, Gustavo Salata Romão, Maristela Carbol Pata, Rosana Maria dos Reis · 2005 · Journal of Pediatric and Adolescent Gynecology
91. Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia
    Lilliana Ciotta, Vincenzo De Leo, Fabiola Galvani, Antonio La Marca, Antonio Cianci · 1999 · Human Reproduction
92. Increased insulin-like growth factor-1 in relation to cardiovascular function in polycystic ovary syndrome: friend or foe?
    Namrata Ajaykumar Desai, Snehal Sanjay Patel · 2015 · Gynecological Endocrinology
93. Insulin resistance and the polycystic ovary syndrome: recent advances
    John E. Nestler · 2000 · Current Opinion in Endocrinology & Diabetes
94. Elevated serum malondialdehyde (MDA), insulin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and thyroid-stimulating hormone (TSH), and reduced antioxidant vitamins in polycystic ovarian syndrome patients
    Abdullah A. Mahmud, Umme H. Anu, Kazi A. Foysal, Mahedi Hasan, Sazaul Morshed Sazib, Abdullah Al Ragib, Asad B. Taher, Md Shajjad Hossain, Mohammad S. Islam, Md Shohel Hossain et al. · 2022 · Narra J
95. Chitosan/PLA-loaded Magnesium oxide nanocomposite to attenuate oxidative stress, neuroinflammation and neurotoxicity in rat models of Alzheimer's disease
    Manickam Rajkumar, Prabha Govindaraj, Karuppaiya Vimala, Ramasundaram Thangaraj, Soundarapandian Kannan · 2023 · Metabolic Brain Disease
96. Effect of ethanolic seed extract of Caesalpinia bonducella on hormones in mifepristone induced PCOS rats
    Balasubramanian Meera Murugesan, Palayyan Muralidharan, Rajeswary Hari · 2020 · Journal of Applied Pharmaceutical Science
97. The polycystic ovary syndrome: treatment with insulin sensitizing agents
    Maria J. Iuorno, John E. Nestler · 1999 · Diabetes Obesity and Metabolism
98. Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndrome
    Carlos Morán, María Raquel Huerta Franco, B. A. Conway-Myers, Gene A. Hines, Ricardo Azziz · 2001 · Fertility and Sterility
99. Developmental programming of insulin resistance: are androgens the culprits?
    Muraly Puttabyatappa, Robert Michael Sargis, Vasantha Padmanabhan · 2020 · Journal of Endocrinology
100. Increased Skeletal Muscle Fiber Cross-Sectional Area, Muscle Phenotype Shift, and Altered Insulin Signaling in Rat Hindlimb Muscles in a Prenatally Androgenized Rat Model for Polycystic Ovary Syndrome
     Auryana DeChick, Rebecca Hetz, Jack Lee, Diana L. Speelman · 2020 · International Journal of Molecular Sciences